SEARCH

8th annual year ended review in lung cancer 2024

Day 3 session

Ultimate Quiz for Students! Test Your Knowledge & Learn Something New | Fun & Educational

Advancing Role of IO Therapy in SCLC | Immunotherapy Breakthroughs in Lung Cancer Treatment

Durvalumab After CRT in LS-SCLC | ADRIATIC Trial Results | NEJM & ASCO 2024 Highlights


Day 2 sessions

Gefitinib vs Gefitinib + Chemo in EGFR-Mutant NSCLC | Long-Term Trial Results Explained

MARIPOSA Study: Resistance to Amivantamab + Lazertinib vs Osimertinib in EGFR+ NSCLC

PALOMA-3: SC vs IV Amivantamab + Lazertinib in EGFR+ NSCLC | Phase 3 OS Results


Day 1 Sessions

ESMO 1538O Environmental pollutants and molecular alterations in non-small cell lung cancer: Insights from the KBP-2020 cohort study

Non-invasive diagnosis of pulmonary nodules by circulating tumor DNA methylation: A prospective multicenter study

Prevalence of pathogenic or likely pathogenic germline variants in cancer predisposition genes among selected patients with lung adenocarcinoma: The GERMLUNG study